Literature DB >> 8491223

Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.

Y Choi1, R C Brunken, R A Hawkins, S C Huang, D B Buxton, C K Hoh, M E Phelps, H R Schelbert.   

Abstract

The goal of this study was to identify the anatomic and physiologic factors affecting left ventricular myocardial 2-[F-18]fluoro-2-deoxy-D-glucose (FDG) uptake and myocardial glucose utilization rates (MRGlc) in normal humans. Eighteen healthy male volunteers were studied in the fasting state (4-19 h) and 16 after oral glucose loading (100 g dextrose) with positron emission tomography (PET) and FDG. Substrate and hormone concentrations were measured in each study. The kinetics of myocardial FDG uptake were evaluated using both a three-compartment model and Patlak graphical analysis. Systolic blood pressures and rate pressure products were similar in the fasting and postglucose states. MRGlc averaged 0.24 +/- 0.17 mumol/min/g in fasting subjects and rose to 0.69 +/- 0.11 mumol/min/g after glucose loading. Phosphorylation rate constant, k3, and MRGlc were linearly related (P < 0.001). Increases in MRGlc following glucose loading were correlated with plasma glucose, insulin and free fatty acid concentrations, ratios of insulin to glucagon levels, and influx rate constants of FDG. Glucose loading improved the diagnostic image quality due to more rapid clearance of tracer from blood and higher myocardial FDG uptake. When MRGlc, glucose and insulin concentrations, and insulin to glucagon ratios exceeded 0.2 mumol/min/g, 100 mg/dl, 19 microU/ml, and 0.2 microU/pg, respectively, myocardial uptake of FDG was always adequate for diagnostic use. FDG image quality and MRGlc were similar after relatively short (6 +/- 2 h) and overnight (16 +/- 2 h) fasting. Significant (P < 0.05) regional heterogeneity of myocardial FDG uptake and MRGlc was observed in both the fasting and the postglucose studies. MRGlc and FDG uptake values in the posterolateral wall were higher than those in the anterior wall and septum. Thus, both 6-h and overnight fasts resulted in similarly low myocardial glucose utilization rates. While MRGlc and myocardial FDG uptake depended on plasma glucose, free fatty acid, and insulin concentrations, the results also suggest an additional dependency on plasma glucagon levels. Regional heterogeneities in myocardial FDG uptake and MRGlc are evident and independent of the subjects' dietary state. These regional heterogeneities need to be considered in studies of patients with cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491223     DOI: 10.1007/BF00169806

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  33 in total

1.  Regional heterogeneity of cardiac substrate metabolism?

Authors:  M Schwaiger; R Hicks
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

Review 2.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

Authors:  J R Neely; H E Morgan
Journal:  Annu Rev Physiol       Date:  1974       Impact factor: 19.318

3.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

4.  Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals.

Authors:  H C Padgett; D G Schmidt; A Luxen; G T Bida; N Satyamurthy; J R Barrio
Journal:  Int J Rad Appl Instrum A       Date:  1989

5.  The disposal of an oral glucose load in healthy subjects. A quantitative study.

Authors:  E Ferrannini; O Bjorkman; G A Reichard; A Pilo; M Olsson; J Wahren; R A DeFronzo
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

6.  Rates of appearance and disappearance of plasma lactate after oral glucose: implications for indirect-pathway hepatic glycogen repletion in man.

Authors:  A Consoli; N Nurjhan; J Gerich
Journal:  Clin Physiol Biochem       Date:  1989

7.  The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.

Authors:  J J Berry; J A Baker; K S Pieper; M W Hanson; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  Validation of PET-acquired input functions for cardiac studies.

Authors:  I N Weinberg; S C Huang; E J Hoffman; L Araujo; C Nienaber; M Grover-McKay; M Dahlbom; H Schelbert
Journal:  J Nucl Med       Date:  1988-02       Impact factor: 10.057

10.  Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin.

Authors:  C K Ng; J E Holden; T R DeGrado; D M Raffel; M L Kornguth; S J Gatley
Journal:  Am J Physiol       Date:  1991-02
View more
  32 in total

Review 1.  Tracer kinetic modeling in nuclear cardiology.

Authors:  T R DeGrado; S R Bergmann; C K Ng; D M Raffel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  FDG-PET: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

4.  Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.

Authors:  Roderick Tung; Brenton Bauer; Heinrich Schelbert; Joseph P Lynch; Martin Auerbach; Pawan Gupta; Christiaan Schiepers; Samantha Chan; Julie Ferris; Martin Barrio; Olujimi Ajijola; Jason Bradfield; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2015-08-10       Impact factor: 6.343

5.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 6.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

7.  Comparison of myocardial F-18 FDG uptake between overnight and non-overnight fasting in non-diabetic healthy subjects.

Authors:  Hyo Young Lee; Hyun-Yeol Nam; Seong Kyu Shin
Journal:  Jpn J Radiol       Date:  2015-05-16       Impact factor: 2.374

8.  A procedure for wall detection in [18F]FDG positron emission tomography heart studies.

Authors:  C Landoni; V Bettinardi; G Lucignani; M C Gilardi; G Striano; F Fazio
Journal:  Eur J Nucl Med       Date:  1996-01

9.  Diagnosis of myocardial viability by fluorodeoxyglucose distribution at the border zone of a low uptake region.

Authors:  Eiji Toyota; Teruki Sone; Kunihiko Yoshikawa; Hiroaki Mimura; Akihiro Hayashida; Nozomi Wada; Kikuko Obase; Koichiro Imai; Ken Saito; Tomoko Maehama; Masao Fukunaga; Kiyoshi Yoshida
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

Review 10.  Myocardial viability: what do we need?

Authors:  H Schoeder; M Friedrich; H Topp
Journal:  Eur J Nucl Med       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.